How could a US HHS staff cut by 20,000 affect the nicotine alternatives industry?

The promised axe has fallen on the workforce at the US Food and Drug Administration (FDA) Center for Tobacco Products (CTP).

Multiple sources have reported that an undetermined number of staff have been dismissed, allegedly including the entirety of the offices responsible for drafting new regulations and setting policy. They appear to be part of a massive reorganisation of the Department of Health and Human Services (HHS) that will see a reduction in overall workforce from 82,000 to 62,000, and a streamlining of departments that will go from 28 divisions down to 15.

Read full article
I'm already a subscriber

Freddie Dawson

Senior contributing editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the TobaccoIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation